NDATOPICALSPONGE
Approved
Jul 2000
Lifecycle
LOE Approaching
Competitive Pressure
25/100
Data completeness
4/8 — Partial
CHLORAPREP ONE-STEP (chlorhexidine gluconate and isopropyl alcohol) by Becton Dickinson. Approved for bacteria. First approved in 2000.
Drug data last refreshed 2h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CHLORAPREP ONE-STEP is a topical antiseptic sponge combining chlorhexidine gluconate and isopropyl alcohol, designed for skin antisepsis prior to invasive procedures. It provides rapid broad-spectrum bacterial reduction on the skin surface, functioning as a pre-procedural antimicrobial agent. The product targets healthcare settings where infection prevention during surgical and interventional procedures is critical.
LOE Approaching10mo to LOE
Product approaching loss of exclusivity in April 2027 with significant competitive pressure (25% intensity), indicating transition from peak revenue phase to defensive positioning requiring strategic portfolio management.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications (1)
Why This Matters for Your Career
Worked on CHLORAPREP ONE-STEP at Becton Dickinson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.